AI Insight
A major study has found that people who use glucosamine supplements for joint pain show a 25% increased risk of progressing from mild cognitive impairment to Alzheimer's disease compared to non-users. The research team also identified potential biological mechanisms that could explain this association between glucosamine supplementation and faster dementia progression.
Why it matters
This finding has significant implications for the millions of people worldwide who regularly take glucosamine for arthritis and joint health. If confirmed by additional research, healthcare providers may need to reconsider recommending glucosamine for elderly patients at risk of cognitive decline.
A major study suggests glucosamine, a popular supplement for joint pain, could be linked to faster progression from mild cognitive impairment to Alzheimer’s disease. Researchers found a 25% higher likelihood of developing dementia among glucosamine users and uncovered biological clues that may explain why.
Source: Popular joint supplement glucosamine linked to faster Alzheimer’s progression